Evidence map›Paper›PMID 28955483›Full record

ArticleRMD open2017

Bone mineral density in patients with psoriatic arthritis: data from the Nord-Trøndelag Health Study 3.

Agnete Malm Gulati, Mari Hoff, Øyvind Salvesen, Alvilde Dhainaut, Anne Grete Semb, Arthur Kavanaugh, Glenn Haugeberg

Open access · goldAbstract read
In one paragraph

Article in RMD open, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis plan.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2022
    Pooled it
  2. The Paradox of Osteoporosis in Spondyloarthropathies.Mediterranean journal of rheumatology · 2024
    Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Agnete Malm GulatiDepartment of Rheumatology, St Olavs Hospital, Trondheim, Norway.
Mari HoffDepartment of Rheumatology, St Olavs Hospital, Trondheim, Norway.
Øyvind SalvesenUnit for Applied Clinical Research, Norwegian University of Science and Technology, Trondheim, Norway.
Alvilde DhainautDepartment of Rheumatology, St Olavs Hospital, Trondheim, Norway.
Anne Grete SembDepartment of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.
Arthur KavanaughDepartment of Rheumatology, Allergy and Immunology, University of California, San Diego, California, USA.
Glenn HaugebergDepartment of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway.
Norwegian University of Science and Technology · NODiakonhjemmet Hospital · NOSt Olav's University Hospital · NOUniversity of California San Diego · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe risk of osteoporosis in patients with psoriatic arthritis (PsA) remains unclear. The aim of this study was to compare bone mineral density (BMD) measured by dual-energy X-ray absorptiometry (DXA) in patients with PsA and controls. PATIENTS AND

methodsPatients with PsA and controls were recruited from the Nord-Trøndelag Health Study (HUNT) 3.

resultsPatients with PsA (n=69) and controls (n=11 703) were comparable in terms of age (56.8 vs 55.3 years, p=0.32), gender distribution (females 65.2% vs 64.3%, p=0.87) and postmenopausal status (75.6% vs 62.8%, p=0.08). Body mass index (BMI) was higher in patients with PsA compared with controls (28.5 vs 27.2 kg/m

conclusionOur population-based data showed comparable BMD in patients with PsA and controls. This supports that the PsA population is not at increased risk of osteoporosis.

Indexed as

bone mineral densityosteoporosisPsoriatic arthritis

Identifiers

PMID28955483
PMCPMC5604602
OpenAlexW2735275092

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.